Living Drugs

Precision therapy cluster for Saxony

About Us

We are an association of leading research institutes and medical facilities from Saxony, including those in Leipzig and Dresden.

Learn more on next page

Our Research

A total of 17 research projects and platforms for the production of allogeneic cell therapeutics from multiple donors in larger batches at a lower price as well as automation play an important role.

Learn more on next page

News & Press

All events, news and information about our SaxoCell cluster

Learn more on next page

Collaboration & Transfer

Overview of all technology and service offers as well as opportunities for cooperation with SaxoCell

Learn more on next page

Development of novel gene and cell therapeutics

SaxoCell has set itself the goal of developing novel gene and cell therapeutics, so-called “living drugs”, which enable this complex form of therapy to be used more widely in various areas of medicine.
The focus is on the efficacy and tolerability of these new cell therapeutics. In addition, allogeneic therapy approaches and automated manufacturing processes should enable socially acceptable costs.
The technologies developed in the cluster are developed together with local company partners and therefore represent an incentive for investors and corresponding industrial partners to get involved in the cluster region.

Latest News

5th May 2023 | Poster presentation

SaxoCell project NK4Therapy poster presentation at the 20th Annual Meeting of the Association for Cancer Immunotherapy (CIMT)

Poster title: “Development of large-scale expansion protocol for NKG2C-positive NK cells for treatment of glioblastoma”

Link to CIMT website

26th April 2023 | Public event

Reden wir über: Genetik – Open discussion on genetic research

Part of special exhibition “Of genes and human beings” at Deutsches Hygiene-Museum Dresden

With SaxoCell members Prof. Dr. Frank Buchholz and Prof. Dr. Michael Sieweke

DHMD | 6 – 8:30 PM

22nd March 2023 | Press release

Start-up project Makrophagen 2.0 one of the winners of the concept phase of the Science4Life Venture Cup

Award for SaxoCell members Prof. Michael Sieweke, Prof. Martin Bornhäuser, Dr. Anke Fuchs and Dr. Ludwig Englmeier

To CMCB (TU Dresden) press release

16th March 2023 | Press release

The TU Dresden spin-off Seamless Therapeutics launches with $12.5M seed financing to advance transformative gene editing platform based on programmable precision designer recombinases in Dresden

To Seamless Therapeutics press release

Upcoming Meetings & Events

SaxoCell@TUD Pitch Battle 2023

How innovative is our campus?

22nd June 2023 | 1 – 5 PM
Dresden

SaxoCell participating at 2023 Long Night of Science

23rd June 2023 | 5 – 11 PM
Fraunhofer IZI Leipzig
Link to Leipzig LNdW website

30th June 2023 | 5 – 11 PM
CRTD Dresden
Link to Dresden LNdW website

ASGCT – Spotlight on Immuno-Oncology

1st – 2nd August 2023
Seattle, USA

Lecture by SaxoCell member Prof. Dr. Michael Hudecek: “Minicircles & Transposon for T Cell Production”

Link to organiser's website

BIO-Europe 2023

6th – 8th November 2023
Munich

Link to organiser's website

Living Drugs

About Us

Our Research

News & Press

Collaboration & Transfer

Development of novel gene and cell therapeutics

Latest News

Upcoming Meetings & Events

Publications Archive

Präzisionstherapie-Cluster

Weitere Informationen